CytomX Therapeutics
Price & Volume
Stats
See moreOpen | $3.98 |
Previous Close | $3.95 |
Day Range | $3.62-$4.02 |
52W Range | $1.72-$8.21 |
Market Cap | $833.8M |
Shares Short | 30M |
Financials
See moreRevenue (12 Mos) | $35.5M |
Revenue Growth (YoY) | -79.9% |
Gross Profit (12 Mos) | $35.5M |
Diluted EPS | -$0.52 |
News
See moreYahoo Finance • last month
CytomX Announces Expansion of Strategic Research Collaboration with Regeneron in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer
Yahoo Finance • last month
Russell 3000 Shuffle: Ocugen, Nektar slated to join among healthcare stocks; Nano-X to drop off
Yahoo Finance • 2 months ago
CytomX Therapeutics to Present at Upcoming June Investor Conferences
Yahoo Finance • 3 months ago
CytomX Therapeutics, Inc. (CTMX) A Top Healthcare Penny Stock Amid Colorectal Cancer Treatment Progress
About
CEO | Dr. Sean A. McCarthy DPHIL |
CFO | Mr. Christopher W. Ogden |
Address | 151 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 69 |